Thermo Fisher Scientific Inc.

NYSE:TMO

555.47 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985
Revenue 42,85744,91539,21132,21825,54224,35820,91818,274.116,965.416,889.613,090.312,509.911,725.910,788.710,109.710,4989,746.43,791.6172,633.0272,205.9952,097.1352,086.3552,188.212,280.5222,471.23,867.63,558.32,932.62,207.41,585.31,249.7949805.5708579500.6383.4331.6265.7
Cost of Revenue 27,63325,41518,97715,71313,71512,99410,9619,459.18,782.78,970.67,339.26,9936,737.36,215.15,960.36,291.85,9422,223.5571,438.0791,191.5161,149.121,158.9791,229.5881,258.6861,264.92,024.61,837.61,542.51,124.7866.3713.1579.8510.2443384.1325.7248.7219.3174.3
Gross Profit 15,22419,50020,23416,50511,82711,3649,9578,8158,182.77,9195,751.15,516.94,988.64,573.64,149.44,206.23,804.41,568.061,194.9481,014.479948.015927.376958.6221,021.8361,206.31,8431,720.71,390.11,082.7719536.6369.2295.3265194.9174.9134.7112.391.4
Gross Profit Ratio 0.3550.4340.5160.5120.4630.4670.4760.4820.4820.4690.4390.4410.4250.4240.410.4010.390.4140.4540.460.4520.4440.4380.4480.4880.4770.4840.4740.490.4540.4290.3890.3670.3740.3370.3490.3510.3390.344
Reseach & Development Expenses 1,3371,4711,4061,1811,003967888754.8692.3691.1395.5376.4340.6287.2246.1249.1238.7170.184152.775134.68146.394155.121171.614176.756171.1367.3337.30269.6103.7000000000
General & Administrative Expenses 000000000000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000000000000
SG&A 6,5697,1276,8425,7644,9304,8234,4104,043.83,724.13,991.42,905.22,828.72,654.52,389.42,196.62,692.32,549.11,110.205761.786626.458568.138564.656620.104646.92673937.6840.7990.7480.8373.2370.6271.7233.6210.6164.4144.6117.191.678.7
Other Expenses -652,3951,7611,6671,7139-28-4.1-15.516.4-563.7000000000000113.6162.3135.7115.28562.342.429.223.418.812.711.110.18.47.8
Operating Expenses 7,90610,99310,0098,6127,6467,5316,8926,176.65,731.26,014.24,063.83,952.73,6433,248.33,039.72,941.42,787.81,280.389914.561761.138714.532719.777791.718823.676957.71,467.21,313.71,105.9835.4539.2413300.9257229.4177.1155.7127.210086.5
Operating Income 7,3188,39310,0287,7944,5943,7832,9682,449.22,336.22,5031,609.61,482.11,245.21,264.91,048.91,229.4974.4241.959263.487237.512184.774155.45334.202198.16248.6375.8407284.2247.3179.8123.668.338.335.617.819.27.512.34.9
Operating Income Ratio 0.1710.1870.2560.2420.180.1550.1420.1340.1380.1480.1230.1180.1060.1170.1040.1170.10.0640.10.1080.0880.0750.0160.0870.1010.0970.1140.0970.1120.1130.0990.0720.0480.050.0310.0380.020.0370.018
Total Other Income Expenses Net -1,020-558-1,187-569-524-41-125-193.3-130.8614.6-133.7-78.4-70.6-88.5-80.6-37-42-42.7920.6575.878-14.8573.429-96.223-13.329-211.115.781.390.5129.183.37.55859.336.531.320.524.79.311.5
Income Before Tax 6,2987,8358,8417,2254,0703,2622,4292,023.91,936.42,087.21,319.51,269.41,126.61,164.6927.11,149.6881.3209.37285.898259.219218.633287.98676.521174.26418.5347.5414301.6239172.611088.1725134.227.422.717.211.8
Income Before Tax Ratio 0.1470.1740.2250.2240.1590.1340.1160.1110.1140.1240.1010.1010.0960.1080.0920.110.090.0550.1090.1180.1040.1380.0350.0760.0070.090.1160.1030.1080.1090.0880.0930.0890.0720.0590.0550.0590.0520.044
Income Tax Expense 2847031,109850374324201-1.4-43.9191.740.411107131.575.8160.9101.743.05487.59740.85245.93692.98726.929112.21733.1170.7174.7110.898.969.233.427.524.917.19.67.34.62.92.2
Net Income 5,9956,9507,7256,3753,6962,9382,2252,021.81,975.41,894.41,273.31,177.91,329.91,035.6850.3994.2761.1168.935223.218361.837200.009309.73-0.781-36.111-174.6181.9239.3190.8140.1103.476.659.247.133.924.620.118.114.39.6
Net Income Ratio 0.140.1550.1970.1980.1450.1210.1060.1110.1160.1120.0970.0940.1130.0960.0840.0950.0780.0450.0850.1640.0950.148-0-0.016-0.0710.0470.0670.0650.0630.0650.0610.0620.0580.0480.0420.040.0470.0430.036
EPS 15.5317.7319.6116.19.247.315.645.124.964.763.533.243.492.572.062.341.810.861.382.221.231.84-0.004-0.22-1.111.121.571.351.110.930.330.180.170.140.110.0980.0890.0740.04
EPS Diluted 15.4517.6419.4615.989.177.245.595.094.924.713.483.213.462.532.012.251.720.841.362.171.21.73-0.004-0.22-1.11.081.411.220.990.820.290.170.160.130.10.0920.0860.0740.038
EBITDA 10,72412,05612,16610,2026,6106,2465,1514,440.74,154.83,653.72,659.22,576.82,2362,107.81,913.12,094.51,818573.063383.17313.604306.881193.079361.648308.975573.3522.4461.4308.9203.2158.8158.539.52.417.9-0.89.8-7.111.41.2
EBITDA Ratio 0.250.2680.310.3170.2590.2560.2460.2430.2450.2160.2030.2060.1910.1950.1890.20.1870.1510.1460.1420.1460.0930.1650.1350.2320.1350.130.1050.0920.10.1270.0420.0030.025-0.0010.02-0.0190.0340.005